Steroid hormones and endocrine disruptors: Recent advances in receptor-mediated actions

Yonago Acta Medica

Volumn 44, Issue 1, 2001, Pages 1-6

  Indarto, Dono ^a,b   Izawa, Masao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b SEBELAS MARET UNIVERSITY   (Indonesia)

Author keywords

Endocrine disrupters; Receptor mediated actions; Steroid hormones

Indexed keywords

EID: 33646522871     PISSN: 05135710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Alvarez L, Randi A, Alvarez P, Piroli O, ChamsonReig A, Lux-Lantos V, et al. Reproductive effects of hexachlorobenzene in female rats. J Appl Toxicol 2000;20:81-87.
2. Bai W, Rowan BG, Allgood VE, O'Malley BW, Weigel NL. Differential phosphorylation of chicken progesterone receptor in hormone dependent and ligand-independent activation. J Biol Chem 1997;272:10457-10463.
3. Brossens JJ, Hayashi N. White JO. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 1999; 140:4809-4820.
4. Brouwers A. Morse DC, Lans MC, Schuur AG, Murk AJ, Klasson-Wehler E, et al. Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanism and possible consequences for animal and human health. Toxicol Ind Health 1998; 14:59-84.
5. Bunone G. Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EOF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996; 15:2174-2183.
6. Chia SE. Endocrine disrupters and male reproductive function. Int J Androl 2000;2:45-46.
7. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999; 103:401-406.
8. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, et al. Androgen receptor activation in prostatic tumor cell lines by insulinlike growth factor-I. keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994; 54:5474-5478.
9. DeVito MJ, Thomas T, Martin T, Umbreit H, Gallo MA. Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD-1 mice. Toxicol Appl Pharmacol 1992;3:284-292.
10. Fenner-Crisp PA. Endocrine modulators: risk characterization and assessment. Toxicol Pathol 2000; 28:438-440.
11. Freedman LP. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 1999;97:5-8.
12. Goetz RM, Thatte HS, Prabhaker P, Cho MR, Michel T, Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1000;96:2788-2793.
13. Goldman ER. New approaches for assessing the etiology and risks of developmental abnormalities from chemical exposure. Reprod Toxicol 1997:11:443-451.
14. Gray LE Jr, Ostby J, Monosson E, Kelce WR. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health 1999a; 15:48-64.
15. Gray EE Jr, Wolf C, Lambright C, Mann P, Price M, Cooper RE, et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketokonazole) and toxic substances (dibuthyl and diethylphthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produce diverse profiles of reproductive malformation in the male rat. Toxicol Ind Health 1999b; 15:94-118.
16. Hollenberg SM, Weinberger C. Ong ES, Cerelli G, Oro AE, Eebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318:635-641.
17. Hunter DS, Hodges EC, Vonier PM, Fuchs-Young R, Gottardis MM, Walker CE. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res 1999;59:3090-3099.
18. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270: 1491-1494.
19. Keith LH. Environmental endocrine disrupters. A handbook of property data. New York: John Wily and Sons; 1997.
20. Klocker H, Culig Z, Eder IE, Nessler Menardi C, Hobisch A, Putz T, et al. Mechanism of androgen receptor activation and possible implication for chemoprevention trials. Eur Urol 1999;35:413-419.
21. Kohn MC, Lucier GM, Clark GC, Sewall CA. A mechanism model of effects of dioxin on gene expression in the rat liver. Toxicol Appl Pharmacol 1993; 120:138-154.
22. Krishnan AV, Stathis P, Permuth SP, Tokes L, Feldman D, Bisphenol A. An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993; 132:2279-2286.
23. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
24. Ladies OS, Smith C, Nicastro SC, Loveless SE, Cook JC, O'Connor JC. Evaluation of the primary humoral immune response following exposure of male rats to 17beta-estradiol or flutamide for 15 days. Toxicol Sci 1998;46:75-82.
25. Loaiza-Perez AI, Seisdedos MT, Kleiman de Pisarev DL, Sancovich HA, Randi AS, Ferramola de Sancovich AM, et al. Hexachlorobenzene, a dioxin-type compound, increases malic enzyme gene transcription through a mechanism involving the thyroid hormone response element. Endocrinology 1999; 140:4142-4151.
26. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
27. Mani SK, Alien JM, Clark JH, Blaustein JD, O'Malley BW. Convergent pathways for steroid hormone and neurotransmitter-induced rat sexual behavior. Science 1994;265:1246-1249.
28. McKenna NJ, O'Malley BW. An issue of tissues: divining the spilt personalities of selective estrogen receptor modulators. Nature Med 2000;6: 960-962.
29. Monosson E, Kelce WR, Lambright C, Ostby J, Gray LE Jr. Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol Ind Health 1999; 15: 65-79.
30. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: im-plications for other environmental estrogens. Environ Health Perspect 1995; 103:83-87.
31. Nishikawa J, Saito K, Goto J, Dakeyama F, Matsuo M, Nishihara T. New screening methods for chemical with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol Appl Pharmacol 1999; 154:76-83.
32. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE Jr. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health 1999; 15:80-93.
33. Osteen KG. Sierra-Rivera E. Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? Semin Reprod Endocrinol 1997;15:301-308.
34. Palanza P, Morellini F, Parmigiani S, Vom Saal FS. Prenatal exposure to endocrine disrupting chemicals: effects on behavioral development. Neurosci Biobehav Rev 1999;23:1011-1027.
35. Pfaff DW. Hormones, genes, and behaviour. Proc Natl Acad Sci USA 1997:94:14213-14216.
36. Safe S, Wang F, Porter W, Duan R, Mcdougal A. Ah receptor agonists as endocrine disrupters: antiestrogenic activity and mechanism. Toxicol Lett 1998; 102:343-347.
37. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics ad antagonists. J Steroid Biochem Mol Biol 1998; 65:143-150.
38. Soto AM, Michaelson CL, Prechtl NV, Weill BC, Sonnenschein C, Olea-Serrano F, et al. Assay to measure estrogen and androgen agonists and antagonists. Adv Exp Med Biol 1998;444:9-23.
39. Spearow JL, Doemeny P, Sera R, Leffler R, Barkley M. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 1999;285:1259-1261.
40. Vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, et al. Prostate erlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997:94:2056-2061.
41. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernarids R, Michalides RJAM. CDK-independent activation of estrogen receptor by cyclin Dl. Cell 1997;88:405-415.